Angiodynamics, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$48Mgeneral payments (2019-2025)
$701Kresearch payments (2019-2025)
17,451clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $2.8M
2020 $2.8M
2021 $4.2M
2022 $6.5M
2023 $9.6M
2024 $11M
2025 $11M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Vascular & Interventional Radiology $11M
Vascular Surgery $6.3M
Diagnostic Radiology $5.2M
Interventional Cardiology $4.5M
Cardiovascular Disease $3.9M
Surgery $3.6M

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Thomas Sos New York, NY Diagnostic Radiology $3,024,194.48
Michael Tarnoff Boston, MA Surgery $1,317,773.91
Lowell Kabnick Morristown, NJ $1,218,260.13
Alejandro Berenstein New York, NY Neurological Surgery $1,009,706.80
David Kumpe Aurora, CO Vascular & Interventional Radiology $842,942.55
Vladimir Zeetser Encino, CA Foot & Ankle Surgery $662,869.75
Rendon Nelson Durham, NC Diagnostic Radiology $470,649.01
Robert Martin Louisville, KY Surgical Oncology $344,296.40
Nadeer Pirani Las Vegas, NV Vascular & Interventional Radiology $306,471.78
John Moriarty Los Angeles, CA Vascular & Interventional Radiology $305,618.18

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.